Also, because high FAK activity in cancer cells advances the formation of a fibrotic and immunosuppressive TME, FAK inhibition combined with immunotherapy—found to double the survival of mice with pancreatic tumors—represents an intriguing anticancer strategy [139]. The gene discussed is PTK2; the disease is cancer.